Insider Transactions

What Vitae Pharmaceuticals, Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	0
Total trades	0	0

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Morris Richard Steven	Chief Financial Officer	Oct 25	Disposition to Issuer · D	−828	$21.00	−$17.4K	0
Gregg Richard	Chief Science Officer	Oct 25	Disposition to Issuer · D	−228,274	$21.00	−$4.79M	228,274
Hatfield Jeffrey S.	Chief Executive Officer	Oct 24	Tender Offer · U	−244,996	$21.00	−$5.14M	244,996
Gunderson Robert V Jr	Director	Oct 24	Tender Offer · U	−15,830	$21.00	−$332K	0
Gunderson Robert V Jr	Director	Oct 24	Tender Offer · U	−11,002	$21.00	−$231K	0
Fratamico Arthur	Chief Business Officer	Oct 24	Tender Offer · U	−13,233	$21.00	−$278K	0
Gregg Richard	Chief Science Officer	Oct 19	Exercise / conversion · M	+6,944	$14.40	+$100K	228,274
Gregg Richard	Chief Science Officer	Oct 19	Exercise / conversion · M	+29,657	$7.13	+$211K	221,330
Gregg Richard	Chief Science Officer	Oct 19	Exercise / conversion · M	+87,301	$3.91	+$341K	191,673
Adage Capital Partners GP, L.l.c.	10% owner	Sep 14	Open-market sale · S	−1,025,000	$20.85	−$21.4M	2,375,000
Hatfield Jeffrey S.	Chief Executive Officer	Sep 14	Open-market sale · S	−50,000	$20.81	−$1.04M	244,996
Hatfield Jeffrey S.	Chief Executive Officer	Apr 29	Grant / award · A	+747	$6.11	+$4.56K	294,996
Morris Richard Steven	Chief Financial Officer	Apr 29	Grant / award · A	+828	$6.11	+$5.06K	828
Fratamico Arthur	Chief Business Officer	Apr 29	Grant / award · A	+2,086	$6.11	+$12.7K	12,086
Gregg Richard	Chief Science Officer	Apr 29	Grant / award · A	+2,100	$6.11	+$12.8K	104,372
Hayden Donald J Jr	Director	Mar 21	Open-market sale · S	−16,130	$7.42	−$120K	0
Hayden Donald J Jr	Director	Mar 21	Exercise / conversion · M	+14,195	$3.45	+$49K	14,195
Hayden Donald J Jr	Director	Mar 21	Exercise / conversion · M	+1,935	$3.45	+$6.68K	1,935
Hayden Donald J Jr	Director	Dec 29	Open-market sale · S	−16,130	$18.00	−$290K	0
Hayden Donald J Jr	Director	Dec 29	Exercise / conversion · M	+16,130	$3.45	+$55.6K	16,130

Page 1 of 5 · showing the 20 most recent Sign up free to view all 95 transactions and filter by insider →

Comments